Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
Publication information:
Chaudhari S, Harris D, Aliakbarian, Luo J, Henke M, Subramaniam, Vernon A, Tavakkoli, Sheu E, Devlin A. Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
Nature Chemical Biology. 2020;17(1):20–29.